Total revenues for fiscal year 2025 reached $34.96 million, a 29.8% increase from the restated 2024 revenue of $26.94 million. Net income attributable to shareholders was $5.78 million in 2025, compared to a restated loss of $18,781 in 2024. Operating income turned positive to $6.05 million in 2025 from a restated operating loss of $0.90 million in 2024. The Company successfully acquired Alchemy International Ltd. (AIL) in October 2025, expanding its regulatory footprint. Working capital improved significantly to $14.88 million as of December 31, 2025, from $0.85 million in the prior year. The filing includes a restatement of 2024 financial statements to correct foreign currency translation adjustments and reclassify client funds.